Study of sepsis-related kidney injury monitoring
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at acute kidney injury that can happen during sepsis (a serious body-wide infection or suspected infection). It may help improve how doctors detect and manage kidney problems early, especially in intensive care or around major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently have (or doctors suspect) sepsis
- Your kidney blood test (creatinine) is normal before this illness, or it can be confirmed
- Your body fluids look normal (your pulse pressure variation is under 12%)
- If you are not in the sepsis group, you must be previously healthy and scheduled for laparoscopic colon cancer surgery
- If you are in the non-sepsis group, your creatinine blood test must be normal within the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system responds in patients who develop sepsis after surgery and how it relates to kidney injury. It aims to help improve care for conditions like this.
This study is testing a combination of methods, including a bedside ultrasound of your kidneys, to help diagnose acute kidney injury that happens as a complication of sepsis. The goal is to find out if this approach can detect kidney problems early so doctors can treat them sooner.
This study looks at substances related to inflammation to better understand sudden kidney problems in people who are very sick in the ICU. It may help improve how kidney injury is predicted and treated after severe illness or major events.
This study tests whether two substances in urine (TIMP2 and IGFBP7) can help doctors predict which patients with sepsis-related kidney problems will get worse. If these markers work, doctors could identify high-risk patients earlier and treat them more aggressively.
This trial tests if a new drug, AZD4144, can help people with sepsis-related acute kidney injury in the ICU. It aims to see if the drug can improve kidney recovery and reduce complications.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.